Verified, then logged.
Sun 22 Nov 2026 · 00:20 KST / 15:20 UTC한국어 | ENSearch /

04 / Policy · Policy

Baropharm calls shareholder meeting on capital reserves

DigitalToday reports that separate proposals would reduce capital reserves to cover accumulated losses and transfer funds to retained earnings.

AI-generated editorial illustration for this article

Key points

  1. 01Baropharm’s 16 Nov 2026 notice convening an extraordinary shareholder meeting
  2. 02Shareholder voting eligibility tied to a 1 Dec 2026 record date
  3. 03Capital reserve reduction proposals scheduled for a vote on 23 Dec 2026

Baropharm, a Korean company, published a notice on 16 Nov 2026 of its decision to convene an extraordinary general meeting of shareholders, according to DigitalToday. The proposed capital reserve reductions await a shareholder vote.

According to DigitalToday, the notice sets 1 Dec 2026 as the record date for voting rights, determining which shareholders are eligible to vote at the meeting.

The meeting is scheduled for 23 Dec 2026 at 9am in the second-floor lounge at Baropharm’s headquarters, DigitalToday reported.

Proposed uses. DigitalToday reports that one agenda item proposes reducing capital reserves to cover accumulated losses. A separate item proposes reducing capital reserves and transferring funds to retained earnings.

Voting procedure. According to DigitalToday, shareholders are scheduled to consider the reduction proposals at the meeting on 23 Dec 2026; whether they will approve them remains undecided.